Yamaguchi, K.* ; Chen, X.* ; Rodgers, B.* ; Miura, F.* ; Bashtrykov, P.* ; Bonhomme, F.* ; Salinas-Luypaert, C.* ; Haxholli, D.* ; Gutekunst, N.* ; Özdemir Aygenli, B. ; Ferry, L.* ; Kirsh, O.* ; Laisné, M.* ; Scelfo, A.* ; Ugur, E.* ; Arimondo, P.B.* ; Leonhardt, H.* ; Kanemaki, M.T.* ; Bartke, T. ; Fachinetti, D.* ; Jeltsch, A.* ; Ito, T.* ; Defossez, P.A.*
Non-canonical functions of UHRF1 maintain DNA methylation homeostasis in cancer cells.
Nat. Commun. 15:2960 (2024)
DNA methylation is an essential epigenetic chromatin modification, and its maintenance in mammals requires the protein UHRF1. It is yet unclear if UHRF1 functions solely by stimulating DNA methylation maintenance by DNMT1, or if it has important additional functions. Using degron alleles, we show that UHRF1 depletion causes a much greater loss of DNA methylation than DNMT1 depletion. This is not caused by passive demethylation as UHRF1-depleted cells proliferate more slowly than DNMT1-depleted cells. Instead, bioinformatics, proteomics and genetics experiments establish that UHRF1, besides activating DNMT1, interacts with DNMT3A and DNMT3B and promotes their activity. In addition, we show that UHRF1 antagonizes active DNA demethylation by TET2. Therefore, UHRF1 has non-canonical roles that contribute importantly to DNA methylation homeostasis; these findings have practical implications for epigenetics in health and disease.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Methyltransferase Dnmt1; Protein Uhrf1; Sra Domain; Recognition; Set; Interacts; Base
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2024
Prepublished im Jahr
0
HGF-Berichtsjahr
2024
ISSN (print) / ISBN
2041-1723
e-ISSN
2041-1723
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 15,
Heft: 1,
Seiten: ,
Artikelnummer: 2960
Supplement: ,
Reihe
Verlag
Nature Publishing Group
Verlagsort
London
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Helmholtz Diabetes Center
PSP-Element(e)
G-502800-001
Förderungen
CNRS Epigenetics and Cell Fate Unit
Agence Nationale de la Recherche
Fondation ARC (ARC labellisation program 2019)
Institut National du Cancer
Universit de Paris IdEx
JSPS Overseas Research Fellowships
Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED
Deutsche Forschungsgemeinschaft
Foundation DFG
Cell and Tissue Imaging (PICT-IBiSA)
Institut Curie
Region Ile-de-France
Fondation Bettencourt Schueller
Agence Nationale de la Recherche (French National Research Agency)
Copyright
Erfassungsdatum
2024-05-24